Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Gene Retrieve available abstracts of 42 articles: HTML format

Single Articles

June 2024
1. VOSOOGHI R, Motavalizadehkakhky A, Mansouri A, Mehrzad J, et al
   Investigating the effect of hesperetin on estrogen receptor alpha (ERalpha) expression, phosphorylation and activity in MCF-7 cells.
   Gene. 2024;911:148357.
   PubMed     Abstract available
   
   
   April 2024
2. DEHGHANIAN F, Ghahnavieh LE, Nilchi AN, Khalilian S, et al
   Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.
   Gene. 2024;916:148424.
   PubMed     Abstract available
   
   
   March 2024
3. QI Q, Zhu M, Li P, Mi Q, et al
   Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
   Gene. 2024 Mar 9:148355. doi: 10.1016/j.gene.2024.148355.
   PubMed     Abstract available
   
   
   
4. YANG Y, Li W, Yang H, Zhang Y, et al
   Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance.
   Gene. 2024;897:148079.
   PubMed     Abstract available
   
   
   January 2024
5. KONG L, Jin X
   Dysregulation of deubiquitination in breast cancer.
   Gene. 2024 Jan 17:148175. doi: 10.1016/j.gene.2024.148175.
   PubMed     Abstract available
   
   
   
6. WASSON MD, Venkatesh J, Cahill HF, McLean ME, et al
   LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.
   Gene. 2024 Jan 12:148165. doi: 10.1016/j.gene.2024.148165.
   PubMed     Abstract available
   
   
   November 2023
7. HOSSEINKHANI N, Hemmat N, Baghbani E, Baghbanzadeh A, et al
   Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.
   Gene. 2023;896:148043.
   PubMed     Abstract available
   
   
   
8. YANG B, Wang YW, Zhang K
   Interactions between circRNA and protein in breast cancer.
   Gene. 2023;895:148019.
   PubMed     Abstract available
   
   
   
9. SINGH A, Thomas Georgy J, Dhananjayan S, Sigamani E, et al
   Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease.
   Gene. 2023 Nov 9:147980. doi: 10.1016/j.gene.2023.147980.
   PubMed     Abstract available
   
   
   July 2023
10. JIA Z, Huang Y, Liu J, Liu G, et al
    Single Nucleotide Polymorphisms Associated with Female Breast cancer Susceptibility in Chinese Population.
    Gene. 2023 Jul 29:147676. doi: 10.1016/j.gene.2023.147676.
    PubMed     Abstract available
    
    
    
11. HATWIK J, Patil HN, Limaye AM
    Proliferative response of ERalpha-positive breast cancer cells to 10 muM enterolactone, and the associated alteration in the transcriptomic landscape.
    Gene. 2023 Jul 13:147640. doi: 10.1016/j.gene.2023.147640.
    PubMed     Abstract available
    
    
    
12. YADAV P, Bandyopadhayaya S, Soni S, Saini S, et al
    Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells.
    Gene. 2023 Jul 11:147636. doi: 10.1016/j.gene.2023.147636.
    PubMed     Abstract available
    
    
    June 2023
13. PAL U, Manjegowda MC, Singh N, Saikia S, et al
    The G-protein-coupled estrogen receptor, a gene co-expressed with ERalpha in breast tumors, is regulated by estrogen-ERalpha signalling in ERalpha positive breast cancer cells.
    Gene. 2023 Jun 4:147548. doi: 10.1016/j.gene.2023.147548.
    PubMed     Abstract available
    
    
    May 2023
14. GHULE PN, Boyd JR, Kabala F, Fritz AJ, et al
    Corrigendum to "Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression" [Gene 872 (2023) 147441].
    Gene. 2023;873:147469.
    PubMed    
    
    
    April 2023
15. ANDREIS TF, de Souza KIW, Vieira IA, Alemar B, et al
    Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Gene. 2023;862:147281.
    PubMed     Abstract available
    
    
    
16. GHULE PN, Boyd JR, Kabala F, Fritz AJ, et al
    Spatiotemporal higher-order chromatin landscape of human histone gene clusters at Histone Locus Bodies during the cell cycle in breast cancer progression.
    Gene. 2023 Apr 22:147441. doi: 10.1016/j.gene.2023.147441.
    PubMed     Abstract available
    
    
    
17. HAMADEH LN, Farhat L, Hilal L, Assi H, et al
    Frequency and Mutational Spectrum of PIK3CA gene mutations in Breast Cancer Patients: Largest and First Report from Lebanon.
    Gene. 2023 Apr 15:147433. doi: 10.1016/j.gene.2023.147433.
    PubMed     Abstract available
    
    
    February 2023
18. WAGHELA BN, Pandit RJ, Puvar A, Shah FD, et al
    Identification of novel exonic variants contributing to hereditary breast and ovarian cancer in west Indian population.
    Gene. 2023;852:147070.
    PubMed     Abstract available
    
    
    January 2023
19. LIN Q, Jiang Y, Zhou F, Zhang Y, et al
    Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Gene. 2023;851:147023.
    PubMed     Abstract available
    
    
    
20. WEI X, Tao S, Mao H, Zhu H, et al
    Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
    Gene. 2023 Jan 27:147230. doi: 10.1016/j.gene.2023.147230.
    PubMed     Abstract available
    
    
    
21. HE Y, Xiao B, Lei T, Xuan J, et al
    LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    Gene. 2023;860:147227.
    PubMed     Abstract available
    
    
    
22. VOUTSADAKIS IA
    Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
    Gene. 2023;857:147179.
    PubMed     Abstract available
    
    
    
23. OUYANG Y, Lu W, Wang Y, Wang B, et al
    Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify thepotential mRNA biomarkers in breast cancer.
    Gene. 2023 Jan 7:147174. doi: 10.1016/j.gene.2023.147174.
    PubMed     Abstract available
    
    
    December 2022
24. YUAN B, Dai Z, Liu G, Xie F, et al
    Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer.
    Gene. 2022 Dec 1:147095. doi: 10.1016/j.gene.2022.147095.
    PubMed     Abstract available
    
    
    November 2022
25. INTABLI H, Gee J, Oesterreich S, Yeoman MS, et al
    Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer.
    Gene. 2022 Nov 5:147022. doi: 10.1016/j.gene.2022.147022.
    PubMed     Abstract available
    
    
    October 2022
26. TARAN Z, Yektaniroumand Digehsaraei S, Salouti M, Amini B, et al
    Methotrexate loaded in alginate beads for controlled drug release against breast cancer.
    Gene. 2022;851:146941.
    PubMed     Abstract available
    
    
    
27. SGHAIER I, Zidi S, El-Ghali RM, Daldoul A, et al
    Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: a case-control study.
    Gene. 2022 Oct 16:146969. doi: 10.1016/j.gene.2022.146969.
    PubMed     Abstract available
    
    
    
28. KUMAR U, Castellanos-Uribe M, May ST, Yague E, et al
    Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer.
    Gene. 2022 Oct 1:146930. doi: 10.1016/j.gene.2022.146930.
    PubMed     Abstract available
    
    
    September 2022
29. VOUTSADAKIS IA
    Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors.
    Gene. 2022 Sep 10:146881. doi: 10.1016/j.gene.2022.146881.
    PubMed     Abstract available
    
    
    May 2022
30. MALCOLM JR, Leese NK, Lamond-Warner PI, Brackenbury WJ, et al
    Widespread association of ERalpha with RMRP and tRNA genes in MCF-7 cells and breast cancers.
    Gene. 2022;821:146280.
    PubMed     Abstract available
    
    
    April 2022
31. BHATT G, Gupta A, Rangan L, Mukund Limaye A, et al
    Global transcriptome analysis reveals partial estrogen-like effects of karanjin in MCF-7 breast cancer cells.
    Gene. 2022 Apr 18:146507. doi: 10.1016/j.gene.2022.146507.
    PubMed     Abstract available
    
    
    
32. AN G, Feng L, Hou L, Li X, et al
    A bioinformatics analysis of zinc finger protein family reveals potential oncogenic biomarkers in breast cancer.
    Gene. 2022 Apr 1:146471. doi: 10.1016/j.gene.2022.146471.
    PubMed     Abstract available
    
    
    March 2022
33. LOPEZ C, Barnon MT, Beacon TH, Nardocci G, et al
    The key role of differential broad H3K4me3 and H3K4ac domains in breast cancer.
    Gene. 2022;826:146463.
    PubMed     Abstract available
    
    
    
34. GULL S, Farooq K, Tayyeb A, Imran Arshad M, et al
    Ethanolic extracts of Pakistani Euphorbiaceous plants induce apoptosis in breast cancer cells through induction of DNA damage and caspase-dependent pathway.
    Gene. 2022 Mar 8:146401. doi: 10.1016/j.gene.2022.146401.
    PubMed     Abstract available
    
    
    February 2022
35. PREETHIKA A, Sonkusare S, Suchetha Kumari N
    Single Nucleotide Polymorphism of Fatty Acid Desaturase Gene and Breast Cancer Risk in Estrogen Receptor Subtype.
    Gene. 2022 Feb 16:146330. doi: 10.1016/j.gene.2022.146330.
    PubMed     Abstract available
    
    
    
36. JAFARINEJAD-FARSANGI S, Moazzam-Jazi M, Naderi Ghale-Noie Z, Askari N, et al
    Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Gene. 2022;821:146328.
    PubMed     Abstract available
    
    
    
37. MORALES F, Perez P, Tapia JC, Lobos-Gonzalez L, et al
    Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Gene. 2022;819:146246.
    PubMed     Abstract available
    
    
    January 2022
38. HEGDE M, Devi Daimary U, Kumar A, Chinnathambi A, et al
    STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis.
    Gene. 2022 Jan 21:146245. doi: 10.1016/j.gene.2022.146245.
    PubMed     Abstract available
    
    
    
39. JABBARZADEH KABOLI P, Luo S, Chen Y, Jomhori M, et al
    Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
    Gene. 2022 Jan 10:146171. doi: 10.1016/j.gene.2021.146171.
    PubMed     Abstract available
    
    
    December 2021
40. HUO X, Shen G, Li J, Wang M, et al
    Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
    Gene. 2021;812:146094.
    PubMed     Abstract available
    
    
    
41. ZHU YY, Zhao YC, Chen C, Xie M, et al
    CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
    Gene. 2021 Dec 2:146100. doi: 10.1016/j.gene.2021.146100.
    PubMed     Abstract available
    
    
    October 2021
42. KAUR B, Mukhlis Y, Natesh J, Penta D, et al
    Identification of hub genes associated with EMT-induced chemoresistance in breast cancer using integrated bioinformatics analysis.
    Gene. 2021 Oct 13:146016. doi: 10.1016/j.gene.2021.146016.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.